查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1811009

2025年精準基因組檢測全球市場報告

Precision Genomic Testing Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

精準基因組檢測市場預計在未來幾年內將快速成長，到2029年將達到231.1億美元，複合年成長率為11.4%。預測期內的成長可歸因於對精準腫瘤學解決方案的需求不斷成長、對罕見疾病診斷的日益關注、對群體基因組學舉措的投資不斷增加、多體學方法的應用不斷擴大以及對無創產前檢測的需求不斷成長。預計在此期間的主要趨勢包括：次世代定序儀技術的進步、液態切片技術的創新、人工智慧在基因組分析中的整合、對多體學數據解讀的改進以及不斷發展的直接面對消費者的基因檢測模式。

預計遺傳疾病盛行率的不斷上升將在未來幾年推動精準基因組檢測市場的成長。遺傳疾病是由個體 DNA 異常引起的疾病，可能涉及單基因突變、多基因突變或染色體的結構或數值變化。遺傳疾病的增加主要是由於母親年齡的成長，因為高齡母親生下患有唐氏症等染色體異常兒童的風險更高。精準基因組檢測透過識別特定的基因突變，支持有針對性的干涉和個人化治療計劃，能夠早期發現和準確診斷遺傳疾病。例如，2025 年 5 月，英國註冊慈善機構 Gene People 報告稱，英國每 25 名兒童中就有 1 名患有遺傳疾病，影響人數超過 240 萬人。此外，英國每年約有 30,000 名新生兒和兒童被診斷出患有遺傳疾病。因此，遺傳疾病的盛行率不斷上升，刺激了精準基因組檢測市場的成長。

精準基因組檢測市場中的公司正專注於開發尖端技術，例如超靈敏的循環腫瘤 DNA 檢測，以提高早期癌症檢測和診斷的準確性。這些檢測能夠識別血液中存在的腫瘤 DNA 微小片段，從而更早、更準確地檢測出與癌症相關的基因突變。例如，2025 年 4 月，美國臨床基因檢測公司 Natera Inc. 推出了超靈敏的 Signatera 基因組分子殘留疾病檢測。此檢測應用患者腫瘤 DNA 和匹配的正常 DNA 的全基因組定序來創建個人化檢測，從而能夠檢測到低至百萬分之一的極低濃度的循環腫瘤 DNA。如此高的靈敏度使得早期發現癌症復發成為可能，從而改善多種癌症類型的治療計劃和患者照護。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球精準基因組檢測：PESTEL分析（政治、社會、科技、環境、法律因素、促進因素與限制因素）
  • 最終用途產業分析
  • 全球精準基因組檢測市場：成長率分析
  • 全球精準基因組檢測市場表現：規模與成長，2019-2024
  • 全球精準基因組檢測市場預測：規模與成長，2024-2029 年，2034 年
  • 全球精準基因組檢測：總潛在市場（TAM）

第6章市場區隔

  • 全球精準基因組檢測市場（依產品及服務、績效及預測），2019-2024 年、2024-2029 年、2034 年
  • 耗材
  • 裝置
  • 服務
  • 全球精準基因組檢測市場：依技術、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 次世代定序
  • 聚合酵素鏈鎖反應
  • 微陣列技術
  • 桑格定序
  • 叢集的規律間隔的短回文重複序列或叢集的規律間隔的短回文重複序列相關系統
  • 其他技術
  • 全球精準基因組檢測市場：應用、績效及預測（2019-2024 年、2024-2029 年及 2034 年）
  • 腫瘤學
  • 心血管疾病
  • 神經系統疾病
  • 生殖健康
  • 罕見疾病
  • 其他用途
  • 全球精準基因組檢測市場：按最終用戶、實際結果和預測，2019-2024 年、2024-2029 年、2034 年
  • 醫院和診所
  • 診斷實驗室
  • 研究和學術機構
  • 其他最終用戶
  • 全球精準基因組檢測市場：按耗材細分（按類型）、實際及預測，2019-2024 年、2024-2029 年、2034 年
  • 試劑和套件
  • 去氧核糖核酸或核糖核酸萃取套件
  • 文庫製備試劑套件
  • 定序試劑
  • 聚合酵素鏈鎖反應檢測試劑套件
  • 緩衝液和酶
  • 全球精準基因組檢測市場：按設備類型、性能和預測細分，2019-2024 年、2024-2029 年、2034 年
  • 次世代定序系統
  • 聚合酵素鏈鎖反應裝置
  • 微陣列設備
  • 去氧核糖核酸分析儀
  • 生物資訊工作站
  • 實驗室自動化系統
  • 全球精準基因組檢測市場：依服務類型、績效及預測細分，2019-2024 年、2024-2029 年、2034 年
  • 基因組數據分析服務
  • 實驗室測試服務
  • 遺傳諮詢服務
  • 臨床解釋服務
  • 合約研究服務
  • 客製化檢測開發服務

第7章 區域和國家分析

  • 全球精準基因組檢測市場：按地區、結果和預測，2019-2024 年、2024-2029 年、2034 年
  • 全球精準基因組檢測市場：依國家、地區、績效及預測（2019-2024 年、2024-2029 年及 2034 年）

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章：西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章：俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 精準基因組檢測市場：競爭格局
  • 精準基因組檢測市場：公司簡介
    • Roche Diagnostics International AG Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • Revvity Inc.
  • QIAGEN NV
  • Exact Sciences Corporation
  • Natera Inc.
  • Myriad Genetics Inc.
  • GenScript Biotech Corporation
  • Fulgent Genetics Inc.
  • Invitae Corporation
  • NeoGenomics Laboratories Inc.
  • Guardant Health Inc.
  • Ambry Genetics Corporation
  • Color Health Inc.
  • Pacific Biosciences
  • Eurofins Genomics LLC
  • Precision Genetics

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

  • 2029年精準基因組檢測市場：哪些國家將帶來新機會
  • 2029年精準基因組檢測市場：細分領域帶來新機會
  • 2029年精準基因組檢測市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手的策略

第36章 附錄

簡介目錄
Product Code: r37112

Precision genomic testing involves the use of advanced genetic analysis to detect specific DNA variations or mutations that impact an individual's risk of disease, diagnosis, prognosis, or treatment response. This approach supports personalized healthcare by enabling tailored prevention strategies, therapeutic interventions, and drug selection based on a person's unique genetic profile.

The key products and services in precision genomic testing include consumables, equipment, and services. Consumables are items intended for single or repeated use and are depleted through routine procedures, examples include laboratory reagents and medical supplies. The testing employs a variety of advanced technologies, such as next-generation sequencing (NGS), polymerase chain reaction (PCR), microarray technology, Sanger sequencing, and CRISPR-associated systems. It is applied across multiple areas, including oncology, cardiovascular diseases, neurological disorders, reproductive health, rare diseases, and more. End users include hospitals and clinics, diagnostic laboratories, research and academic institutions, among others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The precision genomic testing market research report is one of a series of new reports from The Business Research Company that provides precision genomic testing market statistics, including precision genomic testing global market size, regional shares, competitors with precision genomic testing market share, detailed precision genomic testing market segments, market trends and opportunities, and any further data you may need to thrive in the precision genomic testing industry. The precision genomic testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The precision genomic testing market size has grown rapidly in recent years. It will grow from $13.44 billion in 2024 to $15.00 billion in 2025 at a compound annual growth rate (CAGR) of 11.6%. Growth in the historic period can be attributed to the increasing availability of direct-to-consumer genetic testing, rising collaborations between pharmaceutical and diagnostic companies, a heightened focus on preventive healthcare, greater adoption of companion diagnostics, and growing awareness of the importance of early disease detection.

The precision genomic testing market size is expected to see rapid growth in the next few years. It will grow to $23.11 billion in 2029 at a compound annual growth rate (CAGR) of 11.4%. Growth in the forecast period can be attributed to the rising demand for precision oncology solutions, increased focus on rare disease diagnostics, growing investment in population genomics initiatives, expanded use of multi-omics approaches, and the rising demand for non-invasive prenatal testing. Key trends expected during this period include advancements in next-generation sequencing technologies, innovations in liquid biopsy techniques, integration of artificial intelligence in genomic analysis, improvements in multi-omics data interpretation, and the evolution of direct-to-consumer genetic testing models.

The increasing prevalence of genetic disorders is anticipated to drive the growth of the precision genomic testing market in the coming years. Genetic disorders are medical conditions caused by abnormalities in an individual's DNA, which may involve mutations in a single gene, multiple genes, or structural or numerical changes in chromosomes. This rise in genetic disorders is largely attributed to the increasing maternal age, as older mothers face a higher risk of having children with chromosomal abnormalities, such as Down syndrome. Precision genomic testing allows for early detection and accurate diagnosis of genetic disorders by identifying specific genetic mutations, which supports targeted interventions and personalized treatment plans. For example, in May 2025, Gene People, a UK-based registered charity, reported that genetic conditions affect approximately 1 in 25 children, impacting over 2.4 million individuals in the UK. Additionally, around 30,000 newborns and children are diagnosed with a genetic condition each year in the UK. As a result, the rising incidence of genetic disorders is fueling the growth of the precision genomic testing market.

Companies in the precision genomic testing market are focusing on the development of advanced technologies, such as ultra-sensitive circulating tumor DNA assays, to improve early cancer detection and diagnostic accuracy. These assays are capable of identifying minute fragments of tumor-derived DNA present in the bloodstream, which enables earlier and more precise detection of genetic mutations associated with cancer. For instance, in April 2025, Natera Inc., a US-based clinical genetic testing company, launched the ultra-sensitive Signatera genome molecular residual disease test. This test applies whole genome sequencing of both the patient's tumor and matched normal DNA to create a personalized assay, enabling detection of circulating tumor DNA at extremely low concentrations-down to 1 part per million. Such high sensitivity allows for earlier detection of cancer recurrence, improving treatment planning and patient care across multiple cancer types.

In November 2022, Myriad Genetics Inc., a US-based healthcare company, acquired Gateway Genomics LLC for $67.5 million. This acquisition was aimed at strengthening Myriad Genetics' women's health portfolio by expanding into the early prenatal testing segment. The addition of Gateway Genomics' SneakPeek early gender DNA test broadens Myriad's offerings in the consumer genetic testing space. Gateway Genomics LLC, based in the US, specializes in the development of genetic-based tests for consumers, particularly focused on early prenatal applications.

Major players in the precision genomic testing market are Roche Diagnostics International AG, Thermo Fisher Scientific Inc., Danaher Corporation, Agilent Technologies Inc., Illumina Inc., Revvity Inc., QIAGEN N.V., Exact Sciences Corporation, Natera Inc., Myriad Genetics Inc., GenScript Biotech Corporation, Fulgent Genetics Inc., Invitae Corporation, NeoGenomics Laboratories Inc., Guardant Health Inc., Ambry Genetics Corporation, Color Health Inc., Pacific Biosciences, Eurofins Genomics LLC, and Precision Genetics.

North America was the largest region in the precision genomic testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in precision genomic testing report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the precision genomic testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The precision genomic testing market consists of revenues earned by entities by providing services such as gene panel testing, whole genome and exome analysis, pharmacogenomics testing, cancer genomics profiling, hereditary disease screening, and bioinformatics-driven interpretation of genetic data. The market value includes the value of related goods sold by the service provider or included within the service offering. The precision genomic testing market also includes sales of hybridization buffers and enzymes, targeted gene panels, library preparation kits, genomic data compression tools, and rare mutation detection kits. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Precision Genomic Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on precision genomic testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for precision genomic testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The precision genomic testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product And Service: Consumables; Equipment; Services
  • 2) By Technology: Next-Generation Sequencing; Polymerase Chain Reaction; Microarray Technology; Sanger Sequencing; Clustered Regularly Interspaced Short Palindromic Repeats Or Clustered Regularly Interspaced Short Palindromic Repeats-Associated Systems; Other Technologies
  • 3) By Application: Oncology; Cardiovascular Diseases; Neurological Disorders; Reproductive Health; Rare Diseases; Other Applications
  • 4) By End-Users: Hospitals And Clinics; Diagnostic Laboratories; Research And Academic Institutes; Other End-Users
  • Subsegments:
  • 1) By Consumables: Reagents And Kits; Deoxyribonucleic Acid Or Ribonucleic Acid Extraction Kits; Library Preparation Kits; Sequencing Reagents; Polymerase Chain Reaction Assay Kits; Buffers And Enzymes
  • 2) By Equipment: Next-Generation Sequencing Systems; Polymerase Chain Reaction Machines; Microarray Instruments; Deoxyribonucleic Acid Analyzers; Bioinformatics Workstations; Laboratory Automation Systems
  • 3) By Services: Genomic Data Analysis Services; Laboratory Testing Services; Genetic Counseling Services; Clinical Interpretation Services; Contract Research Services; Custom Assay Development Services
  • Companies Mentioned: Roche Diagnostics International AG; Thermo Fisher Scientific Inc.; Danaher Corporation; Agilent Technologies Inc.; Illumina Inc.; Revvity Inc.; QIAGEN N.V.; Exact Sciences Corporation; Natera Inc.; Myriad Genetics Inc.; GenScript Biotech Corporation; Fulgent Genetics Inc.; Invitae Corporation; NeoGenomics Laboratories Inc.; Guardant Health Inc.; Ambry Genetics Corporation; Color Health Inc.; Pacific Biosciences; Eurofins Genomics LLC; Precision Genetics.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Precision Genomic Testing Market Characteristics

3. Precision Genomic Testing Market Trends And Strategies

4. Precision Genomic Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Precision Genomic Testing Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Precision Genomic Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Precision Genomic Testing Market Growth Rate Analysis
  • 5.4. Global Precision Genomic Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Precision Genomic Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Precision Genomic Testing Total Addressable Market (TAM)

6. Precision Genomic Testing Market Segmentation

  • 6.1. Global Precision Genomic Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Consumables
  • Equipment
  • Services
  • 6.2. Global Precision Genomic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Next-Generation Sequencing
  • Polymerase Chain Reaction
  • Microarray Technology
  • Sanger Sequencing
  • Clustered Regularly Interspaced Short Palindromic Repeats Or Clustered Regularly Interspaced Short Palindromic Repeats-Associated Systems
  • Other Technologies
  • 6.3. Global Precision Genomic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Oncology
  • Cardiovascular Diseases
  • Neurological Disorders
  • Reproductive Health
  • Rare Diseases
  • Other Applications
  • 6.4. Global Precision Genomic Testing Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals And Clinics
  • Diagnostic Laboratories
  • Research And Academic Institutes
  • Other End-Users
  • 6.5. Global Precision Genomic Testing Market, Sub-Segmentation Of Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Reagents And Kits
  • Deoxyribonucleic Acid Or Ribonucleic Acid Extraction Kits
  • Library Preparation Kits
  • Sequencing Reagents
  • Polymerase Chain Reaction Assay Kits
  • Buffers And Enzymes
  • 6.6. Global Precision Genomic Testing Market, Sub-Segmentation Of Equipment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Next-Generation Sequencing Systems
  • Polymerase Chain Reaction Machines
  • Microarray Instruments
  • Deoxyribonucleic Acid Analyzers
  • Bioinformatics Workstations
  • Laboratory Automation Systems
  • 6.7. Global Precision Genomic Testing Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Genomic Data Analysis Services
  • Laboratory Testing Services
  • Genetic Counseling Services
  • Clinical Interpretation Services
  • Contract Research Services
  • Custom Assay Development Services

7. Precision Genomic Testing Market Regional And Country Analysis

  • 7.1. Global Precision Genomic Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Precision Genomic Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Precision Genomic Testing Market

  • 8.1. Asia-Pacific Precision Genomic Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Precision Genomic Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Precision Genomic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Precision Genomic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Precision Genomic Testing Market

  • 9.1. China Precision Genomic Testing Market Overview
  • 9.2. China Precision Genomic Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Precision Genomic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Precision Genomic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Precision Genomic Testing Market

  • 10.1. India Precision Genomic Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Precision Genomic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Precision Genomic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Precision Genomic Testing Market

  • 11.1. Japan Precision Genomic Testing Market Overview
  • 11.2. Japan Precision Genomic Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Precision Genomic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Precision Genomic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Precision Genomic Testing Market

  • 12.1. Australia Precision Genomic Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Precision Genomic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Precision Genomic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Precision Genomic Testing Market

  • 13.1. Indonesia Precision Genomic Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Precision Genomic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Precision Genomic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Precision Genomic Testing Market

  • 14.1. South Korea Precision Genomic Testing Market Overview
  • 14.2. South Korea Precision Genomic Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Precision Genomic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Precision Genomic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Precision Genomic Testing Market

  • 15.1. Western Europe Precision Genomic Testing Market Overview
  • 15.2. Western Europe Precision Genomic Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Precision Genomic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Precision Genomic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Precision Genomic Testing Market

  • 16.1. UK Precision Genomic Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Precision Genomic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Precision Genomic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Precision Genomic Testing Market

  • 17.1. Germany Precision Genomic Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Precision Genomic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Precision Genomic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Precision Genomic Testing Market

  • 18.1. France Precision Genomic Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Precision Genomic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Precision Genomic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Precision Genomic Testing Market

  • 19.1. Italy Precision Genomic Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Precision Genomic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Precision Genomic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Precision Genomic Testing Market

  • 20.1. Spain Precision Genomic Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Precision Genomic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Precision Genomic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Precision Genomic Testing Market

  • 21.1. Eastern Europe Precision Genomic Testing Market Overview
  • 21.2. Eastern Europe Precision Genomic Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Precision Genomic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Precision Genomic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Precision Genomic Testing Market

  • 22.1. Russia Precision Genomic Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Precision Genomic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Precision Genomic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Precision Genomic Testing Market

  • 23.1. North America Precision Genomic Testing Market Overview
  • 23.2. North America Precision Genomic Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Precision Genomic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Precision Genomic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Precision Genomic Testing Market

  • 24.1. USA Precision Genomic Testing Market Overview
  • 24.2. USA Precision Genomic Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Precision Genomic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Precision Genomic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Precision Genomic Testing Market

  • 25.1. Canada Precision Genomic Testing Market Overview
  • 25.2. Canada Precision Genomic Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Precision Genomic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Precision Genomic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Precision Genomic Testing Market

  • 26.1. South America Precision Genomic Testing Market Overview
  • 26.2. South America Precision Genomic Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Precision Genomic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Precision Genomic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Precision Genomic Testing Market

  • 27.1. Brazil Precision Genomic Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Precision Genomic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Precision Genomic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Precision Genomic Testing Market

  • 28.1. Middle East Precision Genomic Testing Market Overview
  • 28.2. Middle East Precision Genomic Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Precision Genomic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Precision Genomic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Precision Genomic Testing Market

  • 29.1. Africa Precision Genomic Testing Market Overview
  • 29.2. Africa Precision Genomic Testing Market, Segmentation By Product And Service, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Precision Genomic Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Precision Genomic Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Precision Genomic Testing Market Competitive Landscape And Company Profiles

  • 30.1. Precision Genomic Testing Market Competitive Landscape
  • 30.2. Precision Genomic Testing Market Company Profiles
    • 30.2.1. Roche Diagnostics International AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Illumina Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Precision Genomic Testing Market Other Major And Innovative Companies

  • 31.1. Revvity Inc.
  • 31.2. QIAGEN N.V.
  • 31.3. Exact Sciences Corporation
  • 31.4. Natera Inc.
  • 31.5. Myriad Genetics Inc.
  • 31.6. GenScript Biotech Corporation
  • 31.7. Fulgent Genetics Inc.
  • 31.8. Invitae Corporation
  • 31.9. NeoGenomics Laboratories Inc.
  • 31.10. Guardant Health Inc.
  • 31.11. Ambry Genetics Corporation
  • 31.12. Color Health Inc.
  • 31.13. Pacific Biosciences
  • 31.14. Eurofins Genomics LLC
  • 31.15. Precision Genetics

32. Global Precision Genomic Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Precision Genomic Testing Market

34. Recent Developments In The Precision Genomic Testing Market

35. Precision Genomic Testing Market High Potential Countries, Segments and Strategies

  • 35.1 Precision Genomic Testing Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Precision Genomic Testing Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Precision Genomic Testing Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer